# DESCRIPTION

## BACKGROUND

- motivate protein interaction networks

## SUMMARY

- summarize method of inhibiting pathogenic agents

## DETAILED DESCRIPTION

- describe cell-based multiplex approach
- describe Bithionol's inhibition of pathogenic agents
- define terms used in the invention
- describe administration of Bithionol
- describe inhibition of caspase-dependent pathogenic agents
- describe examples of Bithionol's inhibition of pathogenic agents

### Combination Compositions and Treatments

- motivate combination of Bithionol with antibiotics
- describe composition of Bithionol and antibiotics
- describe administration of combination composition

### Administration of the Bithionol Composition

- define parenteral administration
- describe preparation of pharmaceutical doses

## EXAMPLES

### Example 1. Identification of Host Hub Proteins Exploited by Multiple Pathogenic Toxins

- identify host hub proteins

### Example 2. The Effect of Caspase Mutations on the Sensitivity of Human B-Cells to P. aeruginosa Exotoxin A

- investigate PE sensitivity in human B-cells
- analyze toxin sensitivity in parent/children trios
- associate caspase mutations with PE sensitivity

### Example 3. A Multiplexed Cellular Screen for CCL Drugs that Inhibit Cytotoxic Activities of Bacterial Toxins Exploiting Unique but Interconnected Host Pathways

- screen CCL for drugs that reduce cytotoxicities of bacterial toxins

### Example 4. A Multiplex Protein Function-Based Screen for CCL Drugs that Inhibit Proteolytic Activities of Host Caspase-3, -6, and -7

- screen CCL for drugs that inhibit proteolytic activities of caspases

### Example 5. Bithionol Reduces the Pathogenicity of a Range of Toxins by Inhibiting Host Caspases

- investigate Bithionol's potency in reducing toxin-mediated cytotoxicities

### Example 6. Bithionol Inhibits Cytotoxic Activity of Anthrax Toxins

- test Bithionol's ability to neutralize cytotoxic activity of anthrax toxin

### Example 7. Bithionol Inhibits Ricin and Botulinum Neurotoxin A-Induced Death In Vitro and In Vivo

- test Bithionol's ability to reduce ricin-mediated cytotoxicity
- test Bithionol's efficacy in BoNT/A intoxication in mice

### Example 8. Bithionol Acts as a Zika Virus Inhibitor

- test Bithionol's ability to inhibit Zika virus in infected cells
- determine Bithionol's EC50 in inhibiting Zika virus in host cells

### Example 9. Material and Methods

- list chemicals and reagents
- describe cell culture and cell lines
- detail human B-lymphocytes sensitivity to Pseudomonas toxin-mediated lethality
- outline cellular drug screens
- describe caspases FRET drug tests
- detail toxins treatments and cell viability assays
- outline MAPKK2 cleavage assay
- describe cellular cathepsin B and caspase-1 activity assays
- detail ricin treatment and cell viability assay
- outline mice intoxication studies and other assays

